Bruce Wendel's Net Worth
$1.89 Million
Who is Bruce Wendel?
Bruce Wendel has an estimated net worth of $1.89 Million. This is based on reported shares across multiple companies, which include Abraxis BioScience, Inc., Verastem, Inc., GT Biopharma, Inc., Abraxis BioScience, Inc., Stalar 3 Inc., and Stalar 4, Inc..
SEC CIK
Bruce Wendel's CIK is 0001364846
Past Insider Trading and Trends
2020 was Bruce Wendel's most active year for acquiring shares with 4 total transactions. Bruce Wendel's most active month to acquire stocks was the month of October. 2010 was Bruce Wendel's most active year for disposing of shares, totalling 8 transactions. Bruce Wendel's most active month to dispose stocks was the month of September. 2008 saw Bruce Wendel paying a total of $239,033.22 for 7,356 shares, this is the most they've acquired in one year. In 2010 Bruce Wendel cashed out on 279,163 shares for a total of $4,727,609.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Abraxis BioScience, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -69.78K |
—
|
—
|
0
|
Oct 15
| |||
Form 4
| +2,298.36% | 74.38K |
—
|
—
| 77.61K |
Mar 15
| |||
Form 4
| -10.19% | -367.00 |
$32.67 | -$11,989.89 | 3.24K |
Mar 1
| |||
Form 4
| -6.22% | -239.00 |
$41.17 | -$9,839.63 | 3.6K |
Jan 15
| |||
Form 4
| -42.37% | -797.00 |
$35.42 | -$28,229.74 | 1.08K |
Nov 10
| |||
Form 4
| +2.59% | 591 |
$58.54 | -$19,259.66 | 23.4K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
∞
| 3.68K |
—
|
—
| 3.68K |
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $13.475
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GT Biopharma, Inc. (GTBP) Snapshot price: $5.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
∞
| 352.65K |
$5.17 | $26,298.83 | 352.65K |
Nov 16 - Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Abraxis BioScience, Inc. No price found
Exec. VP Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Stalar 3 Inc. No price found
President, CFO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||